Validity and reliability of the Japanese version of the dyspnea-12 questionnaire in patients with lung cancer
Authors
Kako, J.Kobayashi, M.
Kajiwara, K.
Kimura, Y.
Oosono, Y.
Takegata, M.
Nakano, K.
Matsuda, Y.
Nakamura, N.
Kawashima, N.
Hirano, Y.
Kitae, M.
Yamaguchi, K.
Iwamoto, H.
Hattori, N.
Sawatari, H.
Shiono, S.
Ogino, H.
Nishioka, Y.
Amano, K.
Yorke, Janelle
Affiliation
College of Nursing Art and Science, University of Hyogo, Akashi 673-8588, JapanIssue Date
2022
Metadata
Show full item recordAbstract
Context: The Dyspnea-12 questionnaire is a simple tool to assess dyspnea using qualitative descriptors that include both physical and emotional domains. However, the reliability and validity of the Japanese version in patients with lung cancer have not been assessed. Objective: To determine the reliability and validity of the Japanese version of the Dyspnea-12 questionnaire in patients with lung cancer. Methods: The assessment was based on the numerical rating scale (NRS), Cancer Dyspnea Scale (CDS), and Hospital Anxiety and Depression Scale (HADS). Spearman's correlation assessed the convergent validity of Dyspnea-12 using these three scales. Exploratory factor analysis examined the construct validity. The reliability was verified using Cronbach's alpha. Anxiety, depression, clinical dyspnea, presence of chronic obstructive pulmonary disease (COPD), and patient status were identified by discriminating performance. Results: The analysis included 113 patients with lung cancer. A significant positive correlation was found between Dyspnea-12 and NRS, CDS, and HADS scores. Similar to the original version, factor analysis clearly classified Dyspnea-12 into two components (physical and emotional), thereby confirming its construct validity. Cronbach's alpha values for the total Dyspnea-12 and its physical and emotional components were 0.97, 0.95, and 0.96, respectively. Patients with anxiety, depression, and clinical dyspnea and those in the palliative phase had significantly higher Dyspnea-12 scores than their respective counterparts. The Dyspnea-12 scores of patients with and without COPD were similar. Conclusion: The Japanese version of the Dyspnea-12 questionnaire is a useful and reliable tool to assess the multi-dimensional aspects of dyspnea in patients with lung cancer.Citation
Kako J, Kobayashi M, Kajiwara K, Kimura Y, Oosono Y, Takegata M, et al. Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients With Lung Cancer. Journal of Pain and Symptom Management. Elsevier BV; 2022.Journal
Journal of Pain and Symptom ManagementDOI
10.1016/j.jpainsymman.2022.04.171PubMed ID
35452793Additional Links
https://dx.doi.org/10.1016/j.jpainsymman.2022.04.171Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jpainsymman.2022.04.171
Scopus Count
Collections
Related articles
- Assessment of Breathlessness in Lung Cancer: Psychometric Properties of the Dyspnea-12 Questionnaire.
- Authors: Tan JY, Yorke J, Harle A, Smith J, Blackhall F, Pilling M, Molassiotis A
- Issue date: 2017 Feb
- Adaptation and validation of the Chinese version of Dyspnoea-12 scale in individuals with chronic obstructive pulmonary disease.
- Authors: Choi TCM, Chan LLY, Tsang HC, Vong YP, Cheng YK, To YL, Choo KL, Yorke J
- Issue date: 2021 Oct
- Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer.
- Authors: Uronis HE, Shelby RA, Currow DC, Ahmedzai SH, Bosworth HB, Coan A, Abernethy AP
- Issue date: 2012 Nov
- Italian Version of Cancer Dyspnea Scale: Cultural-Linguistic and Clinical Validation in Patients With Advanced Cancer Disease in Palliative Care Settings.
- Authors: Tinti S, De Maria B, Parati M, Terzoni S, Rossi MC, Da Col D, Pairona G, Longhi C, Giudici E, Pidone I, Alberti A, Sofia M, Ramponi I, Urbano N, Tanaka K, Destrebecq A
- Issue date: 2021 Mar
- Reliability and Validity of the Japanese Version of the Barthel Index Dyspnea Among Patients with Respiratory Diseases.
- Authors: Yamaguchi T, Yamamoto A, Oki Y, Sakai H, Misu S, Iwata Y, Kaneko M, Sawada K, Oki Y, Mitani Y, Ono K, Ishikawa A
- Issue date: 2021